Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

CELZ

Creative Medical Technol... (CELZ)

Creative Medical Technology Holdings Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CELZ
DateTimeSourceHeadlineSymbolCompany
12:52PMiHub NewswireFeaturedCannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA
03/27/20249:00AMBusiness WireCreative Medical Technology Holdings Provides Corporate UpdateNASDAQ:CELZCreative Medical Technology Holdings Inc
03/07/20249:15AMBusiness WireCreative Medical Technology Holdings Inc. Announces FDA Authorization for Groundbreaking Type 1 Diabetes Prevention Therapy Under Expanded AccessNASDAQ:CELZCreative Medical Technology Holdings Inc
03/06/20244:10PMAllPennyStocks.comBiotech Finds Mid-Week Success Following FDA AnnouncementNASDAQ:CELZCreative Medical Technology Holdings Inc
03/06/20247:00AMBusiness WireCreative Medical Technology Holdings, Inc. Receives FDA Orphan Drug Designation for CELZ-101 in Key Transplantation TherapyNASDAQ:CELZCreative Medical Technology Holdings Inc
12/20/20234:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CELZCreative Medical Technology Holdings Inc
11/15/20238:00AMPR Newswire (US)Creative Medical Technology Holdings Provides Corporate UpdateNASDAQ:CELZCreative Medical Technology Holdings Inc
11/03/20234:05PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:CELZCreative Medical Technology Holdings Inc
10/10/20238:00AMPR Newswire (US)Creative Medical Technology Holdings Announces IRB Approval for FDA Cleared Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ ("CELZ-201-DDT") Novel Cell Therapy to Treat Chronic Lower Back PainNASDAQ:CELZCreative Medical Technology Holdings Inc
09/19/20238:00AMPR Newswire (US)Creative Medical Technology Holdings Receives FDA Clearance to Initiate a Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ (CELZ-201-DDT) for the Treatment of Chronic Lower Back PainNASDAQ:CELZCreative Medical Technology Holdings Inc
08/11/20234:45PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CELZCreative Medical Technology Holdings Inc
06/29/20235:38PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CELZCreative Medical Technology Holdings Inc
06/29/20235:37PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CELZCreative Medical Technology Holdings Inc
06/28/20239:01AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CELZCreative Medical Technology Holdings Inc
06/28/20239:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CELZCreative Medical Technology Holdings Inc
06/28/20238:00AMPR Newswire (US)Creative Medical Technology Holdings Regains Compliance With Nasdaq Listing RequirementsNASDAQ:CELZCreative Medical Technology Holdings Inc
06/12/20238:01AMPR Newswire (US)Creative Medical Technology Announces $2 Million Share Repurchase ProgramNASDAQ:CELZCreative Medical Technology Holdings Inc
06/12/20238:00AMPR Newswire (US)Creative Medical Technology Holdings Provides Corporate UpdateNASDAQ:CELZCreative Medical Technology Holdings Inc
06/09/20234:16PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CELZCreative Medical Technology Holdings Inc
06/09/202312:30PMPR Newswire (US)Creative Medical Technology Holdings Announces Reverse Stock SplitNASDAQ:CELZCreative Medical Technology Holdings Inc
05/31/20238:00AMPR Newswire (US)Creative Medical Technology Holdings Announces Successful Completion of the First Phase of its Program with Greenstone Biosciences, Inc. to Develop Next Generation iPSC Pipeline for ImmCelz® Immunotherapy PlatformNASDAQ:CELZCreative Medical Technology Holdings Inc
05/22/20238:30AMPR Newswire (US)Creative Medical Technology Holdings Announces Next Milestone Achievements in ImmCelz® Platform DevelopmentNASDAQ:CELZCreative Medical Technology Holdings Inc
05/18/20238:00AMPR Newswire (US)Creative Medical Technology Holdings Announces Positive Top-Line Study Results for Chronic Lower Back Pain Utilizing its StemSpine® Procedure Using AlloStem™ Allogenic Cell LineNASDAQ:CELZCreative Medical Technology Holdings Inc
05/12/20234:32PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CELZCreative Medical Technology Holdings Inc
05/01/20234:47PMEdgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:CELZCreative Medical Technology Holdings Inc
04/12/20233:30PMAllPennyStocks.comBiotech Up Massively On Follow-Up DataNASDAQ:CELZCreative Medical Technology Holdings Inc
04/12/20238:00AMPR Newswire (US)Creative Medical Technology Announces Positive Top-Line Results for Type 2 Diabetes StudyNASDAQ:CELZCreative Medical Technology Holdings Inc
04/04/20238:00AMPR Newswire (US)Creative Medical Technology Holdings Announces Filing of 2022 Form 10-K and Provides Business UpdateNASDAQ:CELZCreative Medical Technology Holdings Inc
03/31/20234:47PMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:CELZCreative Medical Technology Holdings Inc
03/23/20238:00AMPR Newswire (US)Creative Medical Technology Files Orphan Drug Designation Application with the U.S. FDA Using the ImmCelz® Platform for the Treatment of Brittle Type 1 DiabetesNASDAQ:CELZCreative Medical Technology Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:CELZ